Successful treatment of refractory adult onset Still's disease with rituximab

• Main Authors: N. Belfeki (Author), M. Smiti Khanfir (Author), F. Said (Author), A. Hamzaoui (Author), T. Ben Salem (Author), I. Ben Ghorbel (Author), M. Lamloum (Author), M.H. Houman (Author)
• Format: Book
• Published: PAGEPress Publications, 2016-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Adult-onset Still's disease (AOSD) is an uncommon inflammatory condition of unknown origin. In chronic disease, joint involvement is often predominant and erosions are noted in one third of patients. Therapeutic strategies derive from observational data. Corticosteroids are usually the first-li...